Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $15.1 million.

  • Prestige Consumer Healthcare's Tax Provisions fell 2093.92% to $15.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $80.2 million, marking a year-over-year increase of 2603.86%. This contributed to the annual value of $69.6 million for FY2025, which is 434.57% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Tax Provisions stood at $15.1 million for Q4 2025, which was down 2093.92% from $26.9 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Tax Provisions registered a high of $26.9 million during Q3 2025, and its lowest value of -$59.0 million during Q1 2023.
  • Its 5-year average for Tax Provisions is $12.1 million, with a median of $15.6 million in 2022.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Tax Provisions tumbled by 76415.14% in 2023 and then skyrocketed by 13029.34% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Tax Provisions stood at $15.3 million in 2021, then grew by 5.81% to $16.2 million in 2022, then rose by 2.25% to $16.5 million in 2023, then increased by 15.69% to $19.1 million in 2024, then decreased by 20.94% to $15.1 million in 2025.
  • Its Tax Provisions was $15.1 million in Q4 2025, compared to $26.9 million in Q3 2025 and $14.3 million in Q2 2025.